{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,12,6]],"date-time":"2025-12-06T07:06:58Z","timestamp":1765004818049},"reference-count":24,"publisher":"Wiley","issue":"8","license":[{"start":{"date-parts":[[2001,12,25]],"date-time":"2001-12-25T00:00:00Z","timestamp":1009238400000},"content-version":"vor","delay-in-days":1242,"URL":"http:\/\/onlinelibrary.wiley.com\/termsAndConditions#vor"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Aliment Pharmacol Ther"],"published-print":{"date-parts":[[1998,8]]},"abstract":"<jats:sec><jats:title><jats:italic>Background<\/jats:italic>:<\/jats:title><jats:p>Several studies have shown that acid\u2010suppressing treatment leads to aggravation of <jats:italic>Helicobacter pylori<\/jats:italic> gastritis in the corpus. It remains unclear whether this augmentation of the inflammation reverts to baseline after termination of treatment.<\/jats:p><\/jats:sec><jats:sec><jats:title><jats:italic>Methods<\/jats:italic>:<\/jats:title><jats:p>In 114 <jats:italic>H. pylori<\/jats:italic>\u2010infected duodenal ulcer patients we investigated the gastritis parameters in antral and corpus mucosa before treatment, after 6 and 12\u2003months of therapy, and 6\u2003months after termination of treatment with 15\u2003mg lansoprazole or 150\u2003mg ranitidine\/day.<\/jats:p><\/jats:sec><jats:sec><jats:title><jats:italic>Results<\/jats:italic>:<\/jats:title><jats:p>Lansoprazole and ranitidine led to a significant aggravation of gastritis in the corpus after 6 and 12\u2003months of treatment. However, while there was no change in gastritis in the antrum with ranitidine, treatment with lansoprazole led to partial elimination of <jats:italic>H. pylori<\/jats:italic> with improvement of the inflammation in this part of the stomach. Following termination of therapy, the observed changes reverted to baseline. No increase in intestinal metaplasia and\/or atrophy in the antrum or corpus was observed.<\/jats:p><\/jats:sec><jats:sec><jats:title><jats:italic>Conclusion<\/jats:italic>:<\/jats:title><jats:p>Both substances are associated with an aggravation of <jats:italic>H. pylori<\/jats:italic> gastritis in the corpus. However, only lansoprazole leads to a partial elimination of <jats:italic>H. pylori<\/jats:italic> with improvement of the inflammation in the antrum. The changes provoked by acid\u2010suppressing treatment revert to baseline after termination of therapy.<\/jats:p><\/jats:sec>","DOI":"10.1046\/j.1365-2036.1998.00370.x","type":"journal-article","created":{"date-parts":[[2003,3,11]],"date-time":"2003-03-11T03:37:08Z","timestamp":1047353828000},"page":"735-740","source":"Crossref","is-referenced-by-count":43,"title":["Changes in Helicobacter pylori\u2010induced gastritis in the antrum and corpus during and after 12\u2003months of treatment with ranitidine and lansoprazole in patients with duodenal ulcer disease"],"prefix":"10.1111","volume":"12","author":[{"family":"Meining","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"family":"Kiel","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"family":"Stolte","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"311","published-online":{"date-parts":[[2001,12,25]]},"reference":[{"key":"e_1_2_6_2_2","doi-asserted-by":"publisher","DOI":"10.1136\/gut.36.1.12"},{"key":"e_1_2_6_3_2","unstructured":"SolciaE VillaniL FioccaR et al.Effect of eradication ofHelicobacter pylorion gastritis in duodenal ulcer patients.Scand J Gastroenterol1994; 29 (Suppl. 201): 28\u201334."},{"key":"e_1_2_6_4_2","first-page":"271","article-title":"Elimination of Helicobacter pylori under treatment with omeprazole","volume":"28","author":"Stolte M","year":"1990","journal-title":"Z Gastroenterol"},{"key":"e_1_2_6_5_2","doi-asserted-by":"publisher","DOI":"10.1046\/j.1365-2036.1997.00196.x"},{"key":"e_1_2_6_6_2","doi-asserted-by":"publisher","DOI":"10.1056\/NEJM199604183341603"},{"key":"e_1_2_6_7_2","article-title":"Gastritis development and acid suppression therapy revisited. Results of a randomised clinical study with long\u2010term follow\u2010up","volume":"112","author":"Lundell L","year":"1997","journal-title":"Gastroenterol"},{"key":"e_1_2_6_8_2","doi-asserted-by":"publisher","DOI":"10.1053\/gast.1997.v112.pm9041231"},{"key":"e_1_2_6_9_2","doi-asserted-by":"publisher","DOI":"10.1111\/j.1440-1746.1991.tb01468.x"},{"key":"e_1_2_6_10_2","first-page":"89","article-title":"Relationship between the degree of Helicobacter pylori colonization and the degree and activity of gastritis, surface epithelial degeneration and mucus secretion","volume":"33","author":"Stolte M","year":"1995","journal-title":"Z Gastroenterol"},{"key":"e_1_2_6_11_2","doi-asserted-by":"publisher","DOI":"10.1016\/S0934-8840(11)80965-5"},{"key":"e_1_2_6_12_2","doi-asserted-by":"publisher","DOI":"10.1136\/gut.35.4.455"},{"key":"e_1_2_6_13_2","doi-asserted-by":"publisher","DOI":"10.1136\/bmj.289.6447.717"},{"key":"e_1_2_6_14_2","doi-asserted-by":"publisher","DOI":"10.1136\/gut.36.4.539"},{"key":"e_1_2_6_15_2","doi-asserted-by":"publisher","DOI":"10.1016\/S0016-5085(96)70056-2"},{"key":"e_1_2_6_16_2","article-title":"Presence of immunoglobulin in gastric juice is related to infection with Helicobacter pylori and is pH dependent","volume":"114","author":"Dchsenk\u00fckn T","year":"1998","journal-title":"Gastroenterology"},{"key":"e_1_2_6_17_2","doi-asserted-by":"publisher","DOI":"10.3109\/00365528809093891"},{"key":"e_1_2_6_18_2","doi-asserted-by":"publisher","DOI":"10.7326\/0003-4819-121-3-199408010-00001"},{"key":"e_1_2_6_19_2","doi-asserted-by":"publisher","DOI":"10.1007\/BF00199508"},{"key":"e_1_2_6_20_2","doi-asserted-by":"publisher","DOI":"10.1053\/gast.1996.v111.pm8780570"},{"key":"e_1_2_6_21_2","article-title":"Helicobacter pylori Eradikationstherapie bei Patienten mit atrophischer Korpusgastritis","volume":"81","author":"W\u00fcndisch T","year":"1997","journal-title":"Verh Dtsch Ges Pathol"},{"key":"e_1_2_6_22_2","doi-asserted-by":"publisher","DOI":"10.1097\/00000478-199610000-00001"},{"key":"e_1_2_6_23_2","first-page":"3554","article-title":"A human model of gastric carcinogenesis","volume":"48","author":"Correa P","year":"1988","journal-title":"Cancer Res"},{"key":"e_1_2_6_24_2","unstructured":"MeiningA Bayerd\u00f6rfferE M\u00fcllerP et al.Gastric Carcinoma Risk Index in Patients Infected withHelicobacter pylori.Virchows Arch1998; 452: 312\u201314."},{"key":"e_1_2_6_25_2","unstructured":"MeiningA&StolteM.Different expression ofH. pylorigastritis in relatives of gastric carcinoma patients.Gut1996; 39 (Suppl. 2): A17\u201318."}],"container-title":["Alimentary Pharmacology &amp; Therapeutics"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.wiley.com\/onlinelibrary\/tdm\/v1\/articles\/10.1046%2Fj.1365-2036.1998.00370.x","content-type":"unspecified","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.wiley.com\/onlinelibrary\/tdm\/v1\/articles\/10.1046%2Fj.1365-2036.1998.00370.x","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/onlinelibrary.wiley.com\/doi\/pdf\/10.1046\/j.1365-2036.1998.00370.x","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2023,9,11]],"date-time":"2023-09-11T06:58:44Z","timestamp":1694415524000},"score":1,"resource":{"primary":{"URL":"https:\/\/onlinelibrary.wiley.com\/doi\/10.1046\/j.1365-2036.1998.00370.x"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[1998,8]]},"references-count":24,"journal-issue":{"issue":"8","published-print":{"date-parts":[[1998,8]]}},"alternative-id":["10.1046\/j.1365-2036.1998.00370.x"],"URL":"https:\/\/doi.org\/10.1046\/j.1365-2036.1998.00370.x","archive":["Portico"],"relation":{},"ISSN":["0269-2813","1365-2036"],"issn-type":[{"value":"0269-2813","type":"print"},{"value":"1365-2036","type":"electronic"}],"subject":[],"published":{"date-parts":[[1998,8]]}}}